The systemic nature of scleroderma-related lung disease has led many to implicate circulating factors in the pathogenesis of some of its organ impairment. PubMed, Curr Rheumatol Rep, 2013 Dec;15(12):381. (Also see: Pulmonary Fibrosis Research, and Causes of Scleroderma: Cytokines)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.